Physiology
Recent Submissions
-
(Frontiers in Physiology, 2019-08-13)Background: The dual Na+ and cardiac Ca2+-release channel inhibitor, Flecainide (FLEC) is effective in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), a disease caused by mutations in cardiac ...
-
(Frontiers in Physiology, 2019-07-30)[This corrects the article DOI: 10.3389/fphys.2014.00220.]. http://hdl.handle.net/1803/10006